[1] Contact your GP or diabetes care team if you notice: Consistently elevated blood glucose readings HbA1c rising above your agreed target Unexplained weight gain Return of diabetes symptoms (increased thirst, frequent urination, fatigue) Severe and persistent abdominal pain (with or without vomiting), which could indicate pancreatitis Symptoms of gallbladder disease (pain in upper right abdomen, nausea, vomiting) Signs of dehydration (dizziness, dry mouth, reduced urination) New or worsening visual symptoms, particularly if you have diabetic retinopathy Your healthcare provider may consider dose escalation (Ozempic starts at 0.25 mg weekly for 4 weeks as an initiation dose only, then 0.5 mg, with possible increases to 1 mg and 2 mg weekly doses if needed and tolerated) or investigate other factors affecting your diabetes control
The FDA has officially approved semaglutide to address their concerns about managing their weight effectively
In contrast, the response to exogenously supplied S 0 species (DMTS) was not significantly affected by SQR deletion, as expected (Figure 4C, ultimate panel)
Musculoskeletal pain is not listed as a recognised adverse reaction in the UK SmPC
Detoxification: Supports liver function by helping to remove toxins, heavy metals, and harmful substances
More recent studies have reported that complex factors, such as infection, environmental exposures, diabetes and metabolic disorders, and genetics, may all contribute to dementia risk
